QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
USA - NASDAQ:QIPT - CA74880P1045 - Common Stock
2.31 USD
+0.01 (+0.43%)
We assign a fundamental rating of 3 out of 10 to QIPT. QIPT was compared to 100 industry peers in the Health Care Providers & Services industry. QIPT may be in some trouble as it scores bad on both profitability and health. QIPT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
QIPT had negative earnings in the past year.
QIPT had a positive operating cash flow in the past year.
In the past 5 years QIPT reported 4 times negative net income.
In the past 5 years QIPT always reported a positive cash flow from operatings.
1.2 Ratios
QIPT has a worse Return On Assets (-4.35%) than 68.00% of its industry peers.
QIPT has a Return On Equity (-10.01%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| ROIC | N/A |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 71.51%, QIPT belongs to the top of the industry, outperforming 87.00% of the companies in the same industry.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
QIPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
QIPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QIPT has more shares outstanding
The number of shares outstanding for QIPT has been increased compared to 5 years ago.
QIPT has a worse debt/assets ratio than last year.
2.2 Solvency
QIPT has an Altman-Z score of 0.35. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of QIPT (0.35) is worse than 77.00% of its industry peers.
The Debt to FCF ratio of QIPT is 5.81, which is a neutral value as it means it would take QIPT, 5.81 years of fcf income to pay off all of its debts.
QIPT has a better Debt to FCF ratio (5.81) than 62.00% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that QIPT is somewhat dependend on debt financing.
QIPT has a Debt to Equity ratio (0.71) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.81 | ||
| Altman-Z | 0.35 |
ROIC/WACCN/A
WACC8.52%
2.3 Liquidity
A Current Ratio of 1.15 indicates that QIPT should not have too much problems paying its short term obligations.
QIPT has a worse Current ratio (1.15) than 62.00% of its industry peers.
QIPT has a Quick Ratio of 1.15. This is a bad value and indicates that QIPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QIPT has a worse Quick ratio (0.75) than 79.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
The earnings per share for QIPT have decreased strongly by -90.91% in the last year.
QIPT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.21%.
QIPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.16% yearly.
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
3.2 Future
The Earnings Per Share is expected to grow by 97.77% on average over the next years. This is a very strong growth
QIPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.85% yearly.
EPS Next Y-64.33%
EPS Next 2Y23.79%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue Next Year-7.25%
Revenue Next 2Y9.25%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Also next year QIPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
94.00% of the companies in the same industry are more expensive than QIPT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaply inside the industry as 93.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.31 | ||
| EV/EBITDA | 4.97 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y2.12%
5. Dividend
5.1 Amount
No dividends for QIPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:QIPT (11/14/2025, 8:19:04 PM)
2.31
+0.01 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners47.08%
Inst Owner Change0.28%
Ins Owners15.18%
Ins Owner Change0%
Market Cap100.35M
Revenue(TTM)229.68M
Net Income(TTM)-10.26M
Analysts80
Price Target3.72 (61.04%)
Short Float %3.83%
Short Ratio2.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-9.06%
Max Revenue beat(2)-0.65%
Revenue beat(4)0
Avg Revenue beat(4)-8.24%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-0.65%
Revenue beat(8)0
Avg Revenue beat(8)-5.71%
Revenue beat(12)1
Avg Revenue beat(12)-4.96%
Revenue beat(16)2
Avg Revenue beat(16)-4.19%
PT rev (1m)-0.64%
PT rev (3m)-10.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-141.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.44 | ||
| P/FCF | 6.31 | ||
| P/OCF | 3.36 | ||
| P/B | 0.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.97 |
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.37
FCFY15.85%
OCF(TTM)0.69
OCFY29.8%
SpS5.29
BVpS2.36
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.51% | ||
| FCFM | 6.93% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.81 | ||
| Debt/EBITDA | 2 | ||
| Cap/Depr | 33.78% | ||
| Cap/Sales | 6.09% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 81.97% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | 0.35 |
F-Score3
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y-64.33%
EPS Next 2Y23.79%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
Revenue Next Year-7.25%
Revenue Next 2Y9.25%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
EBIT growth 1Y-209.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1642.71%
EBIT Next 3Y181.71%
EBIT Next 5Y154.85%
FCF growth 1Y-39.09%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y-12.62%
OCF growth 3Y23.7%
OCF growth 5Y33.42%
QUIPT HOME MEDICAL CORP / QIPT FAQ
Can you provide the ChartMill fundamental rating for QUIPT HOME MEDICAL CORP?
ChartMill assigns a fundamental rating of 3 / 10 to QIPT.
What is the valuation status of QUIPT HOME MEDICAL CORP (QIPT) stock?
ChartMill assigns a valuation rating of 2 / 10 to QUIPT HOME MEDICAL CORP (QIPT). This can be considered as Overvalued.
Can you provide the profitability details for QUIPT HOME MEDICAL CORP?
QUIPT HOME MEDICAL CORP (QIPT) has a profitability rating of 2 / 10.
Can you provide the financial health for QIPT stock?
The financial health rating of QUIPT HOME MEDICAL CORP (QIPT) is 2 / 10.
What is the expected EPS growth for QUIPT HOME MEDICAL CORP (QIPT) stock?
The Earnings per Share (EPS) of QUIPT HOME MEDICAL CORP (QIPT) is expected to decline by -64.33% in the next year.